Melatonin and aging: relevance for clinical approach?
Fauteck
J D
JD
Jenapharm GmbH & Co. KG, Jena, Germany. Jandirk.fauteck@jenapharm.de
Dittgen
M
M
Farker
K
K
Hoffmann
A
A
Hoffmann
H
H
Lerchl
A
A
Wittkowski
W
W
D000200:Action Potentials / Q000187:drug effects; D000375:Aging / Q000378:metabolism*; D002940:Circadian Rhythm / Q000502:physiology; D006801:Humans; D008297:Male; D008550:Melatonin / Q000378:metabolism* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019579:Neocortex / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D044094:Receptors, Melatonin; D012016:Reference Values; D012463:Saliva / Q000378:metabolism; D012890:Sleep / Q000187:drug effects; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology
D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D044094:Receptors, Melatonin; D008550:Melatonin